STOCK TITAN

Chime Financial: Crosslink sells 160,100 shares

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

Chime Financial, Inc. (CHYM) director James Feuille reported indirect sales of Class A common stock by Crosslink Crossover Fund VI, L.P. Across four reported entries, the fund sold 160,100 shares: 64,000 at a weighted average of $33.53 on November 13, 2026; 60,100 at $34.36 on November 16; and 32,940 at $33.43 plus 3,060 at $34.00 on November 17. The footnotes state that the fund directly held the shares and that Feuille, a managing member of its general partner, disclaims beneficial ownership except to the extent of his pecuniary interest. No Rule 10b5-1 plan is reported.

Insider Feuille James
Role Director
Sold 160,100 shs ($5.42M)
Type Security Shares Price Value
Sale Class A Common Stock F4, F2 32,940 $33.43 $1.10M
Sale Class A Common Stock F5, F2 3,060 $34.00 $104K
Sale Class A Common Stock F3, F2 60,100 $34.36 $2.07M
Sale Class A Common Stock F1, F2 64,000 $33.53 $2.15M
Holding Class A Common Stock F6, F7 -- -- --
Holding Class A Common Stock F8, F9 -- -- --
Holding Class A Common Stock F10, F11 -- -- --
Holding Class A Common Stock F12, F13 -- -- --
Holding Class A Common Stock F14, F15 -- -- --
Holding Class A Common Stock F16 -- -- --
Holding Class A Common Stock -- -- --
Holdings After Transaction: Class A Common Stock — 6,400,607 shares (Indirect, By Crosslink Crossover Fund VI, L.P.); Class A Common Stock — 7,949,067 shares (Indirect, By Crosslink Ventures VII, L.P.); Class A Common Stock — 3,405,896 shares (Indirect, Crosslink Ventures VII-B, L.P.); Class A Common Stock — 842,661 shares (Indirect, By Crosslink Bayview VII, LLC); Class A Common Stock — 62,000 shares (Indirect, By Crosslink Ventures VII Holdings, LLC); Class A Common Stock — 207,539 shares (Indirect, By Trust); Class A Common Stock — 23,315 shares (Direct)
Footnotes (16)
  1. F1. The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $33.46 to $33.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.
  2. F2. Shares are directly held by Crosslink Crossover Fund VI, L.P. ("CO VI"). Crossover Fund VI Management, L.L.C. ("CF VI Mgr") is the general partner of CO VI and the Reporting Person is a managing member of CF VI Mgr. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
  3. F3. The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $34.01 to $34.61, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.
  4. F4. The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $32.93 to $33.92, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.
  5. F5. The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $33.94 to $34.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.
  6. F6. The shares held by Crosslink Ventures VII, L.P. ("CV VII") as reported herein reflect a pro rata distribution in kind, effected by CV VII to its general partner and limited partners for no additional consideration subsequent to the Reporting Person's most recent Form 4 filing, which were exempt from reporting pursuant to Rule 16a-13.
  7. F7. Shares are directly held by CV VII. Crosslink Ventures VII Holdings, LLC ("CV VII Hldgs") is the general partner of CV VII and the Reporting Person is a managing member of CV VII Hldgs. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
  8. F8. The shares held by Crosslink Ventures VII-B, L.P. ("CV VII-B") as reported herein reflect a pro rata distribution in kind, effected by CV VII-B to its general partner and limited partners for no additional consideration subsequent to the Reporting Person's most recent Form 4 filing, which were exempt from reporting pursuant to Rule 16a-13.
  9. F9. Shares are directly held by CV VII-B. CV VII Hldgs is the general partner of CV VII-B and the Reporting Person is a managing member of CV VII Hldgs. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
  10. F10. The shares held by Crosslink Bayview VII, LLC ("CB VII") as reported herein reflect pro rata distributions in kind, effected by CB VII to its members for no additional consideration subsequent to the Reporting Person's most recent Form 4 filing, which were exempt from reporting pursuant to Rule 16a-13.
  11. F11. Shares are directly held by CB VII. CV VII Hldgs is the manager of CB VII and the Reporting Person is a managing member of CV VII Hldgs. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
  12. F12. The shares held by CV VII Hldgs as reported herein reflect the receipt of shares pursuant to pro rata distributions in kind, effected by CB VII and CB VII-B, for no additional consideration subsequent to the Reporting Person's most recent Form 4 filing, which were exempt from reporting pursuant to Rule 16a-13.
  13. F13. Shares are directly held by CV VII Hldgs. The Reporting Person is a managing member of CV VII Hldgs and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
  14. F14. The shares reported herein reflect the receipt of shares pursuant to a pro rata distribution in kind, effected by CB VII, for no additional consideration subsequent to the Reporting Person's most recent Form 4 filing, which were exempt from reporting pursuant to Rule 16a-13.
  15. F15. The shares are held by an irrevocable trust, of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his proportionate pecuniary interest therein.
  16. F16. The shares are held by a revocable trust, of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his proportionate pecuniary interest therein.
Shares sold, November 13, 2026 64,000 shares Indirect sale entry by Crosslink Crossover Fund VI, L.P.
Weighted average sale price, November 13, 2026 $33.53 per share Indirect sale entry by Crosslink Crossover Fund VI, L.P.
Shares sold, November 16, 2026 60,100 shares Indirect sale entry by Crosslink Crossover Fund VI, L.P.
Weighted average sale price, November 16, 2026 $34.36 per share Indirect sale entry by Crosslink Crossover Fund VI, L.P.
Shares sold, November 17, 2026 32,940 shares First indirect sale entry by Crosslink Crossover Fund VI, L.P.
Weighted average sale price, November 17, 2026 $33.43 per share First indirect sale entry by Crosslink Crossover Fund VI, L.P.
Shares sold, November 17, 2026 3,060 shares Second indirect sale entry by Crosslink Crossover Fund VI, L.P.
Weighted average sale price, November 17, 2026 $34.00 per share Second indirect sale entry by Crosslink Crossover Fund VI, L.P.
weighted average price financial
"weighted average price for the reported share sales"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
pecuniary interest regulatory
"disclaims beneficial ownership except to the extent of his pecuniary interest"
pro rata distribution in kind financial
"shares held by Crosslink Ventures VII, L.P. following a pro rata distribution in kind"
Rule 16a-13 regulatory
"distributions in kind exempt from reporting pursuant to Rule 16a-13"
beneficial ownership regulatory
"disclaims beneficial ownership of these shares"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many CHYM shares were sold in James Feuille's Form 4?

Crosslink Crossover Fund VI, L.P. reported indirect sales totaling 160,100 shares from November 13 through November 17, 2026. The entries report weighted-average prices of $33.53, $34.36, $33.43 and $34.00 per share. No Rule 10b5-1 plan is reported.

What price ranges were reported for the CHYM share sales?

The reported sales occurred within these price ranges: $33.46 to $33.65 for the November 13, 2026 entry; $34.01 to $34.61 for November 16; and $32.93 to $33.92 and $33.94 to $34.06 for the two November 17 entries. The reported prices for each entry are weighted averages.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Feuille James

(Last)(First)(Middle)
C/O CHIME FINANCIAL, INC.
101 CALIFORNIA STREET, SUITE 500

(Street)
SAN FRANCISCO CALIFORNIA 94111

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Chime Financial, Inc. [ CHYM ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/13/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A Common Stock11/13/2026S64,000D$33.53(1)6,496,707IBy Crosslink Crossover Fund VI, L.P.(2)
Class A Common Stock11/16/2026S60,100D$34.36(3)6,436,607IBy Crosslink Crossover Fund VI, L.P.(2)
Class A Common Stock11/17/2026S32,940D$33.43(4)6,403,667IBy Crosslink Crossover Fund VI, L.P.(2)
Class A Common Stock11/17/2026S3,060D$34(5)6,400,607IBy Crosslink Crossover Fund VI, L.P.(2)
Class A Common Stock7,949,067(6)IBy Crosslink Ventures VII, L.P.(7)
Class A Common Stock3,405,896(8)ICrosslink Ventures VII-B, L.P.(9)
Class A Common Stock842,661(10)IBy Crosslink Bayview VII, LLC(11)
Class A Common Stock62,000(12)IBy Crosslink Ventures VII Holdings, LLC(13)
Class A Common Stock162,293(14)IBy Trust(15)
Class A Common Stock45,246IBy Trust(16)
Class A Common Stock23,315D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $33.46 to $33.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.
2. Shares are directly held by Crosslink Crossover Fund VI, L.P. ("CO VI"). Crossover Fund VI Management, L.L.C. ("CF VI Mgr") is the general partner of CO VI and the Reporting Person is a managing member of CF VI Mgr. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
3. The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $34.01 to $34.61, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.
4. The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $32.93 to $33.92, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.
5. The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $33.94 to $34.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.
6. The shares held by Crosslink Ventures VII, L.P. ("CV VII") as reported herein reflect a pro rata distribution in kind, effected by CV VII to its general partner and limited partners for no additional consideration subsequent to the Reporting Person's most recent Form 4 filing, which were exempt from reporting pursuant to Rule 16a-13.
7. Shares are directly held by CV VII. Crosslink Ventures VII Holdings, LLC ("CV VII Hldgs") is the general partner of CV VII and the Reporting Person is a managing member of CV VII Hldgs. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
8. The shares held by Crosslink Ventures VII-B, L.P. ("CV VII-B") as reported herein reflect a pro rata distribution in kind, effected by CV VII-B to its general partner and limited partners for no additional consideration subsequent to the Reporting Person's most recent Form 4 filing, which were exempt from reporting pursuant to Rule 16a-13.
9. Shares are directly held by CV VII-B. CV VII Hldgs is the general partner of CV VII-B and the Reporting Person is a managing member of CV VII Hldgs. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
10. The shares held by Crosslink Bayview VII, LLC ("CB VII") as reported herein reflect pro rata distributions in kind, effected by CB VII to its members for no additional consideration subsequent to the Reporting Person's most recent Form 4 filing, which were exempt from reporting pursuant to Rule 16a-13.
11. Shares are directly held by CB VII. CV VII Hldgs is the manager of CB VII and the Reporting Person is a managing member of CV VII Hldgs. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
12. The shares held by CV VII Hldgs as reported herein reflect the receipt of shares pursuant to pro rata distributions in kind, effected by CB VII and CB VII-B, for no additional consideration subsequent to the Reporting Person's most recent Form 4 filing, which were exempt from reporting pursuant to Rule 16a-13.
13. Shares are directly held by CV VII Hldgs. The Reporting Person is a managing member of CV VII Hldgs and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
14. The shares reported herein reflect the receipt of shares pursuant to a pro rata distribution in kind, effected by CB VII, for no additional consideration subsequent to the Reporting Person's most recent Form 4 filing, which were exempt from reporting pursuant to Rule 16a-13.
15. The shares are held by an irrevocable trust, of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his proportionate pecuniary interest therein.
16. The shares are held by a revocable trust, of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his proportionate pecuniary interest therein.
/s/ James Feuille11/17/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading